Novartis | NOVN - Marktkapitalisierung

Aktienkurs
116.78
Täglich Wechseln
0.10 0.09%
Monatlich
-1.22%
Jährlich
27.56%
Q2 Prognose
114.36




Marktkapitalisierung Veränderung Datum
AbbVie USD 364.22B 20.46B 2026-05
Alcon AG USD 24.12B 12.94B 2026-05
Almirall EUR 2.51B 251.72M 2026-05
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Autolus Therapeutics Ltd USD 529.63M 0 2026-05
Bayer EUR 37.69B 1.01B 2026-05
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Fresenius EUR 22.59B 5B 2026-05
Fresenius Medical Care EUR 10.89B 429.56M 2026-05
Genmab DKK 20.48B 1.02B 2025-12
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
GRIFOLS EUR 3.69B 1.9B 2026-05
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
J&J USD 579.15B 78.91B 2026-03
Lakefront Biotherapeutics EUR 1.58B 147.61M 2026-05
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 52.48B 826.08M 2026-05
Merck USD 297.1B 35.84B 2026-03
Novartis USD 232.75B 75B 2026-05
Novo Nordisk A/S DKK 1.45T 421.31B 2026-05
Orion EUR 9.83B 890.75M 2026-03
Pfizer USD 147.4B 6.42B 2026-05
Philips EUR 21.43B 1.05B 2026-05
Recordati EUR 10.41B 261.71M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
UCB EUR 46.41B 13.94B 2025-12